ASC30
AURORA-2
Ascletis Pharma (China) Co · Phase 3 · Recruiting · Enrollment 1560
| Arm | Population | Dose | Weeks | Estimand | Weight change |
|---|---|---|---|---|---|
| ASC30 Cohort 1 | Obesity + T2D | n/r | n/r | n/r | n/r |
| ASC30 Cohort 2 | Obesity + T2D | n/r | n/r | n/r | n/r |
| ASC30 Cohort 3 | Obesity + T2D | n/r | n/r | n/r | n/r |
| Placebo Cohort 4 | Obesity + T2D | n/r | n/r | n/r | n/r |